Route 52 Closures Approved for Irish Fest Parade
Manhattan Village Board Meeting | Feb. 3, 2026
Article Summary: The Village Board authorized the closure of U.S. Route 52 and Manhattan-Monee Road to accommodate the annual Irish Fest Parade. The closures will take place on the morning of Saturday, March 7, 2026.
Irish Fest Road Closure Key Points:
-
Event: Annual Irish Fest Parade.
-
Date: Saturday, March 7, 2026.
-
Closure Time: 10:30 a.m. to 12:30 p.m.
-
Affected Roads: Manhattan-Monee Road and U.S. Route 52 (North Street).
The Manhattan Village Board on Tuesday, February 3, 2026, cleared the way for one of the community’s most popular annual events, approving the road closures necessary for the Irish Fest Parade.
As part of the consent agenda, the board adopted a resolution authorizing the use of U.S. Route 52 and Manhattan-Monee Road on Saturday, March 7, 2026.
According to the resolution, the parade requires the closing of Manhattan-Monee Road and U.S. Route 52 starting at Thelma Street. The route turns west onto Manhattan-Monee Road and proceeds south on U.S. Route 52, concluding at Second Street.
The closures are scheduled to last from 10:30 a.m. until 12:30 p.m. The village agrees to assume full responsibility for traffic control and detour management during the event.
Latest News Stories
Cook County offers loans after latest tax bill delays
Illinois Quick Hits: Storms cause damage, closures
Extension of pension buyout program to drop $144B liability
Schools face bus funding, cost challenges
‘Family Month’ backer cites biology, declining birth rates in defense of resolution
Aldermen say lawmakers failed to address illegal cannabis sales near schools
Illinois Quick Hits: Oak Park woman charged with child care fraud
Florida attorney general appeals Chicago judge’s ‘lawless’ transgender ruling
Congressman calls out Chicago schools’ academic woes
Everyday Economics: A stable labor market is not enough
Fishermen advocate begins campaign against offshore wind, ‘industrializing’ of the ocean
Sorensen drug-pricing bill draws criticism from former FDA official